Literature DB >> 1118087

Relation of large birthweight to maternal diabetes mellitus.

E O Horger, M C Miller, E D Conner.   

Abstract

The records of 517 pregnancies which terminated in the delivery of infants weighing 9 lb or more were reviewed. The obstetric patient most likely to deliver a large birthweight infant was characterized. Toxemia, prolonged labor, and puerperal morbidity occurred with increased frequency. Many of the deliveries were complicated by fetopelvic disproportion with resultant increase in mid-forceps deliveries, cesarean sections, and perinatal morbidity. Five of the 517 patients delivering large birthweight infants were known to have diabetes mellitus prior to the pregnancy included in this study. An additional 369 patients were evaluated with intravenous glucose tolerance tests. Thirty-eight (10.3%) of the 369 tested proved to have diabetic glucose tolerance curves. The likelihood of finding maternal diabetes mellitus increased with the infant's birthweight. Multiple regression analysis of other clinical variables failed to predict which patients would prove to have diabetes. Identification of diabetic puerperas requires that glucose tolerance tests be performed in all who delivered large birthweight infants.

Entities:  

Mesh:

Year:  1975        PMID: 1118087

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  A comparison of maternal and cord blood glucose levels in diabetic and non-diabetic Nigerians in relation to birth weight and maternal body mass index.

Authors:  J O Akpan
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

2.  Effect of gestational diabetes on insulin receptors in human placenta.

Authors:  S Durán-García; J G Nieto; A M Cabello
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Can the birth of a large infant predict risk for atherosclerotic vascular disease in the mother?

Authors:  J Spjuth; G Larsson; P Nilsson-Ehle; B Schersten; B Astedt
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.